National Bank of Canada’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding GDRX
FPM
VCM
SLG
VPM
PTC
PGCM
National Bank of Canada's GDRX Position: Q1 2026 in Review
National Bank of Canada reduced its GoodRx Holdings (GDRX) stake by 58% in Q1 2026, selling an estimated $17.5K and leaving 5,335 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2323.
National Bank of Canada first reported a position in GDRX in Q4 2021 and has held it in 15 quarters since. The position peaked at $984K in Q4 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.
- National Bank of Canada held 5,335 shares of GoodRx Holdings worth $10.5K as of Q1 2026.
- National Bank of Canada sold 7,479 GoodRx Holdings shares in Q1 2026, an estimated $17.5K.
- GoodRx Holdings made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2323 holding.
- National Bank of Canada first reported a position in GoodRx Holdings in Q4 2021 and has held it in 15 quarters since.
- National Bank of Canada's GoodRx Holdings position peaked at $984K in Q4 2021.
- 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.
Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.